Skip to main content
. 2015 Jan 22;7:11–17. doi: 10.2147/CPAA.S73472

Figure 1.

Figure 1

Study design.

Notes: End of pharmacokinetic sampling occurred at days 7 and 21. End of study evaluation was performed 14 (±2) days after everolimus administration in the second time period.

Abbreviation: R, randomization.